6505--Ropinirole Tablet

Description

{"description":"Presolicitation Notice\n\nPage 1 of \n\nPresolicitation Notice\n\nPage 1 of 3\nPresolicitation Notice\n*=Required Field\nPresolicitation Notice\n\nPage 4 of 4\nDESCRIPTION\nPresolicitation Notice\n\nPresolicitation Notice\n\nPage 3 of 3\n\nPresolicitation Notice\n*=Required Field\nPresolicitation Notice\n\nPage 1 of 3\nPage 1 of \nPage 1 of \nPRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0019 for an unrestrictive procurement for Ropinirole HCLTablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package unit of use is bottles. Solicitation #36E79726R0019 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 23, 2026, with a tentative closing date of May 07, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov.\n \n \nThe estimated annual requirements are as follows:\n\nITEM\n\nDESCRIPTION\nPACKAGE SIZE (Tablets per Bottle)\nTOTAL\nESTIMATED\nANNUAL\nUSAGE\n(Bottles)\n1\nROPINIROLE HCL 0.25MG TAB\n100\n20,608\n2\nROPINIROLE HCL 0.25MG TAB\n500\n7,335\n3\nROPINIROLE HCL 0.5MG TAB\n100\n25,269\n4\nROPINIROLE HCL 0.5MG TAB\n500\n10,332\n5\nROPINIROLE HCL 1MG TAB\n100\n33,807\n6\nROPINIROLE HCL 1MG TAB\n500\n12,384\n7\nROPINIROLE HCL 2MG TAB\n100\n16,075\n8\nROPINIROLE HCL 2MG TAB\n500\n8,029\n9\nROPINIROLE HCL 3MG TAB\n100\n4,853\n10\nROPINIROLE HCL 3MG TAB\n500\n2,835\n11\nROPINIROLE HCL 4MG TAB\n100\n4,153\n12\nROPINIROLE HCL 4MG TAB\n500\n2,924\n13\nROPINIROLE HCL 5MG TAB\n100\n4,549\n\n\n\n\n"}